Renal Cancer - Results from #6920

Efficacy of everolimus in patients with advanced renal cell carcinoma refractory or intolerant to VEGFR-TKIs and safety compared with prior VEGFR-TKI treatment - Abstract June 6, 2014

Randomized, controlled, double-blind, cross-over trial assessing treatment preference for pazopanib versus sunitinib in patients with metastatic renal cell carcinoma: PISCES Study - Abstract June 6, 2014

Treatment algorithm for metastatic renal cell carcinoma--recommendations based on evidence and clinical practice - Abstract June 6, 2014

Body composition by computed tomography as a predictor of toxicity in patients with renal cell carcinoma treated with sunitinib - Abstract June 5, 2014

Strategies for the management of adverse events associated with mTOR inhibitors - Abstract June 5, 2014

Transitional cell carcinoma arising in a calyceal cyst mimicking a cystic renal tumour - Abstract June 5, 2014

A phase Ib study of combined VEGFR and mTOR inhibition with vatalanib and everolimus in patients with advanced renal cell carcinoma - Abstract June 5, 2014

Lessons learned from the International Renal Cell Carcinoma-Venous Thrombus Consortium (IRCC-VTC) - Abstract June 5, 2014

Ovarian metastasis of clear cell renal cell carcinoma: A case report - Abstract June 5, 2014

Impact of everolimus blood concentration on its anti-cancer activity in patients with metastatic renal cell carcinoma - Abstract June 4, 2014

Assessing the burden of complications after surgery for clinically localized kidney cancer by age and comorbidity status - Abstract June 4, 2014

Association between R.E.N.A.L. nephrometry score and perioperative outcomes following open partial nephrectomy under cold ischemia - Abstract June 4, 2014

Impact of surgery in management of pancreatic metastases of renal cell cancer - Abstract June 2, 2014

Inferior vena cava tumor thrombus after partial nephrectomy for renal cell carcinoma - Abstract June 2, 2014

Clinical outcomes in patients with metastatic renal cell carcinoma receiving everolimus or temsirolimus after sunitinib - Abstract June 2, 2014

MRI evaluation of the adaptive response of the contralateral kidney following nephrectomy in patients with renal cell carcinoma - Abstract June 2, 2014

Rationale and protocol of RESORT, a randomized, open-label, multicenter phase II study to evaluate the efficacy of sorafenib in patients with advanced renal cell carcinoma after radical resection of the metastases - Abstract May 30, 2014

Renal cell carcinoma: Molecular biology and targeted therapy - Abstract May 30, 2014

Sarcomatoid renal cell carcinoma: Follow-up of a series of 23 patients - Abstract May 30, 2014

Practice uptake in France before and after the 2010 French guidelines on kidney cancer - Abstract May 30, 2014

Page 347 of 457